Molecular-based, PCR-less identification of species-specific phenotypic markers of resistance and susceptibility, as they are clinically relevant end products of many genetic pathways
Directly from patient whole blood samples, no need to wait for positive blood cultures.
Diagnostic tests help guide appropriate use of antibiotics and decrease inappropriate antibiotic use by lessening the need for clinicians to treat patients empirically.
The only antimicrobial susceptibility testing that can directly test on patient whole blood samples
120 MINUTES FOR A DIAGNOSTIC USED IN A PHYSICIAN’S OFFICE OR THE ED FOR OUTPATIENT BLOODSTREAM INFECTION RESISTANCE PROFILING
240 MINUTES FOR A DIAGNOSTIC USED FOR INPATIENT HOSPITAL ACQUIRED INFECTION (HAI) RESISTANCE PROFILING
Site-specific antibiogram
Antimicrobial Stewardship program
Patient whole blood sample
Pathogen identification
Direct resistance profiling
Categorization
Resistance profiling
Viral
Gram –
Fungal
Gram +
Phenotypic culture
MIC or resistance reporting
MIC or resistance reporting
Amplicillin Culture
Cefazolin culture
Gentamicin culture
Tobramycin culture
Comprehensive phenotypic culture
Molecular-based phenotypic resistance
• Phenotypic testing
• Evidence-based
• 60-120 minutes
• MIC reporting
• Multiplexed
Multi-drug resistance
Liao lab at Stanford University
Multi-site Clinical feasibility testing